Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Yatra received Nasdaq notification letter » 18:20
07/31/20
07/31
18:20
07/31/20
18:20
YTRA

Yatra

$0.72 /

-0.0257 (-3.43%)

Yatra Online announced…

Yatra Online announced that on July 29, 2020, the company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market notifying the company that, for the last 30 consecutive business days, the company's ordinary shares had not maintained a minimum closing bid price of $1.00 per share pursuant to Nasdaq Listing Rule 5550(a)(2). The Nasdaq letter does not result in the immediate delisting of the company's ordinary shares from The Nasdaq Capital Market.

ShowHide Related Items >><<
YTRA Yatra
$0.72 /

-0.0257 (-3.43%)

YTRA Yatra
$0.72 /

-0.0257 (-3.43%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
  • 19
    Jun
YTRA Yatra
$0.72 /

-0.0257 (-3.43%)

Hot Stocks
Yatra announces alliance with upGrad Enterprise » 08:47
07/14/20
07/14
08:47
07/14/20
08:47
YTRA

Yatra

$0.74 /

-0.0058 (-0.78%)

Yatra Online has forged…

Yatra Online has forged an alliance with upGrad Enterprise, the B2B arm of upGrad, India's largest online higher education company. With Yatra's aim to diversify its portfolio beyond travel, this partnership shall enable its corporate clients to deliver advance learning and skill development for their employees. From deployment-ready workforce within 6 months, to reducing employee attrition and aligning L&D plan with business growth strategy, upGrad Enterprise will work closely with Yatra's corporate and SME clientele. The edtech major will be providing deep skilling programs that align with the client's desired business outcomes to deliver impact at scale.

ShowHide Related Items >><<
YTRA Yatra
$0.74 /

-0.0058 (-0.78%)

YTRA Yatra
$0.74 /

-0.0058 (-0.78%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
  • 19
    Jun
YTRA Yatra
$0.74 /

-0.0058 (-0.78%)

Hot Stocks
Yatra, Zaggle partner to offer expense automation solutions » 08:47
07/08/20
07/08
08:47
07/08/20
08:47
YTRA

Yatra

$0.72 /

-0.0254 (-3.40%)

Yatra Online and Zaggle,…

Yatra Online and Zaggle, a leading FinTech start-up, have announced their partnership to deliver streamlined, integrated expense automation solutions for corporates and SMEs in India. This partnership, will enable Yatra to deliver an efficient expense management system and corporate card program along with its existing online travel solution.

ShowHide Related Items >><<
YTRA Yatra
$0.72 /

-0.0254 (-3.40%)

YTRA Yatra
$0.72 /

-0.0254 (-3.40%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
  • 19
    Jun
YTRA Yatra
$0.72 /

-0.0254 (-3.40%)

Over a month ago
Syndicate
Yatra 12.5M share Spot Secondary priced at 80c » 06:18
06/19/20
06/19
06:18
06/19/20
06:18
YTRA

Yatra

$0.97 /

+0.0051 (+0.53%)

H.C. Wainwright acted as…

H.C. Wainwright acted as sole book running manager for the offering.

ShowHide Related Items >><<
YTRA Yatra
$0.97 /

+0.0051 (+0.53%)

YTRA Yatra
$0.97 /

+0.0051 (+0.53%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
  • 19
    Jun
YTRA Yatra
$0.97 /

+0.0051 (+0.53%)

Syndicate
Yatra files to sell ordinary shares, no amount given » 16:38
06/18/20
06/18
16:38
06/18/20
16:38
YTRA

Yatra

$0.97 /

+0.0051 (+0.53%)

H.C. Wainwright & Co.…

H.C. Wainwright & Co. is acting as the sole book-running manager for the proposed offering.

ShowHide Related Items >><<
YTRA Yatra
$0.97 /

+0.0051 (+0.53%)

YTRA Yatra
$0.97 /

+0.0051 (+0.53%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
YTRA Yatra
$0.97 /

+0.0051 (+0.53%)

On The Fly
Fly Intel: Pre-market Movers » 09:10
06/08/20
06/08
09:10
06/08/20
09:10
GILD

Gilead

$76.67 /

-0.85 (-1.10%)

, MGTA

Magenta Therapeutics

$9.95 /

+0.71 (+7.68%)

, FCAU

Fiat Chrysler

$10.40 /

+0.52 (+5.27%)

, THO

Thor Industries

$99.99 /

+0.97 (+0.98%)

, REVG

REV Group

$7.96 /

+0.685 (+9.42%)

, AZN

AstraZeneca

$53.87 /

+ (+0.00%)

, PCG

PG&E

$12.51 /

+0.66 (+5.57%)

, YTRA

Yatra

$1.50 /

+0.24 (+19.05%)

, KZR

Kezar Life Sciences

$6.87 /

-0.86 (-11.13%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
YTRA Yatra
$1.50 /

+0.24 (+19.05%)

THO Thor Industries
$99.99 /

+0.97 (+0.98%)

REVG REV Group
$7.96 /

+0.685 (+9.42%)

PCG PG&E
$12.51 /

+0.66 (+5.57%)

MGTA Magenta Therapeutics
$9.95 /

+0.71 (+7.68%)

KZR Kezar Life Sciences
$6.87 /

-0.86 (-11.13%)

GILD Gilead
$76.67 /

-0.85 (-1.10%)

FCAU Fiat Chrysler
$10.40 /

+0.52 (+5.27%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

GILD Gilead
$76.67 /

-0.85 (-1.10%)

06/08/20 Jefferies
Jefferies' Welford questions benefit to AstraZeneca of merger with Gilead
06/08/20 Bernstein
Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
06/08/20 Jefferies
Jefferies' Yee sees Gilead merger with AstraZeneca as unlikely
06/08/20 JPMorgan
JPMorgan sees low proability of AstraZeneca, Gilead merger
MGTA Magenta Therapeutics
$9.95 /

+0.71 (+7.68%)

06/08/20 Goldman Sachs
Magenta Therapeutics upgraded to Buy from Neutral at Goldman Sachs
01/15/20 BTIG
BTIG sees 'no real reason' for Magenta Therapeutics sell-off
12/06/19 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
12/06/19 Goldman Sachs
Magenta Therapeutics assumed with a Neutral at Goldman Sachs
FCAU Fiat Chrysler
$10.40 /

+0.52 (+5.27%)

03/24/20 UBS
Tesla and BMW upgraded, Ford downgraded at UBS
03/11/20 Morgan Stanley
Morgan Stanley cuts estimates for GM, Ford and FCA on coronavirus 'demand shock'
12/18/19 Evercore ISI
Evercore ISI upgrades Fiat Chrysler to Outperform after Peugeot deal formalized
12/18/19 Evercore ISI
Fiat Chrysler upgraded to Outperform from In Line at Evercore ISI
THO Thor Industries
$99.99 /

+0.97 (+0.98%)

06/01/20 Monness Crespi
Camping World price target raised to $24 from $18 at Monness Crespi
04/17/20 Wolfe Research
Thor Industries initiated with an Outperform at Wolfe Research
04/14/20 KeyBanc
Thor Industries price target lowered to $62 from $69 at KeyBanc
04/08/20 Northcoast
Thor Industries, Camping World downgraded at Northcoast after RV industry checks
REVG REV Group
$7.96 /

+0.685 (+9.42%)

03/25/20 Wells Fargo
REV Group price target lowered to $4 from $10 at Wells Fargo
01/14/20 Wells Fargo
REV Group downgraded to Underweight from Equal Weight at Wells Fargo
12/16/19 Morgan Stanley
REV Group cut to Underweight on labor issues, weak RV market at Morgan Stanley
12/16/19 Morgan Stanley
REV Group downgraded to Underweight from Equal Weight at Morgan Stanley
AZN AstraZeneca
$53.87 /

+ (+0.00%)

PCG PG&E
$12.51 /

+0.66 (+5.57%)

06/05/20 BofA
PG&E resumed with a Buy at BofA
05/15/20 Barclays
Barclays upgrades Utilities sector along with PG&E and two others
05/15/20 Barclays
PG&E upgraded to Overweight from Equal Weight at Barclays
05/06/20 Mizuho
PG&E price target raised to $13.50 from $12.50 at Mizuho
YTRA Yatra
$1.50 /

+0.24 (+19.05%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
KZR Kezar Life Sciences
$6.87 /

-0.86 (-11.13%)

06/04/20 H.C. Wainwright
Kezar Life Sciences price target raised to $12 from $9 at H.C. Wainwright
05/05/20 H.C. Wainwright
Kezar Life Sciences price target lowered to $9 from $15 at H.C. Wainwright
07/29/19 H.C. Wainwright
Kezar Life Sciences initiated with a Buy at H.C. Wainwright
THO Thor Industries
$99.99 /

+0.97 (+0.98%)

REVG REV Group
$7.96 /

+0.685 (+9.42%)

PCG PG&E
$12.51 /

+0.66 (+5.57%)

MGTA Magenta Therapeutics
$9.95 /

+0.71 (+7.68%)

KZR Kezar Life Sciences
$6.87 /

-0.86 (-11.13%)

GILD Gilead
$76.67 /

-0.85 (-1.10%)

FCAU Fiat Chrysler
$10.40 /

+0.52 (+5.27%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

PCG PG&E
$12.51 /

+0.66 (+5.57%)

GILD Gilead
$76.67 /

-0.85 (-1.10%)

FCAU Fiat Chrysler
$10.40 /

+0.52 (+5.27%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

THO Thor Industries
$99.99 /

+0.97 (+0.98%)

PCG PG&E
$12.51 /

+0.66 (+5.57%)

KZR Kezar Life Sciences
$6.87 /

-0.86 (-11.13%)

GILD Gilead
$76.67 /

-0.85 (-1.10%)

FCAU Fiat Chrysler
$10.40 /

+0.52 (+5.27%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

REVG REV Group
$7.96 /

+0.685 (+9.42%)

PCG PG&E
$12.51 /

+0.66 (+5.57%)

KZR Kezar Life Sciences
$6.87 /

-0.86 (-11.13%)

GILD Gilead
$76.67 /

-0.85 (-1.10%)

FCAU Fiat Chrysler
$10.40 /

+0.52 (+5.27%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

Hot Stocks
Ebix considers countersuit against Yatra following merger deal termination » 07:34
06/08/20
06/08
07:34
06/08/20
07:34
EBIX

Ebix

$28.05 /

+0.98 (+3.62%)

, YTRA

Yatra

$1.50 /

+0.24 (+19.05%)

Ebix (EBIX) issued a…

Ebix (EBIX) issued a statement in response to the termination of the merger agreement with Yatra (YTRA). On May 14, 2020, Yatra Online, Inc., a Cayman Islands exempted company limited by shares, entered into an agreement with Ebix extending the outside date of the Merger Agreement, dated July 16, 2019, by and between Yatra, Ebix and EbixCash Travels Inc., a direct, wholly-owned subsidiary of Ebix to June 4, 2020. The Merger Agreement contained certain termination rights for Ebix and Yatra, including, among others, the right of either party to terminate the Merger Agreement if the Merger has not been consummated on or prior to the Outside Date. The Outside Date was extended to June 4, 2020 in order to provide the parties with time to determine whether they could reach mutual agreement on an amendment of certain terms of the Merger Agreement. After the expiration of the Outside Date and the failure of the two parties to agree on the terms of an amended Merger Agreement by the Outside Date, Yatra terminated the Merger Agreement on June 5, 2020 and filed suit against Ebix in the Delaware Court of Chancery for breach of contract. The company said, "Ebix worked diligently to fulfill its obligations under the Merger Agreement and thus strongly disagrees with the allegations set forth in the complaint. Ebix intends to enforce all of its rights under the Merger Agreement, and is currently considering all options, including a countersuit against Yatra, on account of multiple breaches of the Merger Agreement."

ShowHide Related Items >><<
YTRA Yatra
$1.50 /

+0.24 (+19.05%)

EBIX Ebix
$28.05 /

+0.98 (+3.62%)

EBIX Ebix
$28.05 /

+0.98 (+3.62%)

05/12/20 Craig-Hallum
Ebix shares and estimates 'have put in a floor,' says Craig-Hallum
05/12/20 BMO Capital
Ebix price target lowered to $34 from $43 at BMO Capital
04/30/20 Craig-Hallum
Ebix price target lowered to $75 from $80 at Craig-Hallum
03/26/20 Craig-Hallum
Ebix to be top performer as investors realize stock mispriced, says Craig-Hallum
YTRA Yatra
$1.50 /

+0.24 (+19.05%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
EBIX Ebix
$28.05 /

+0.98 (+3.62%)

EBIX Ebix
$28.05 /

+0.98 (+3.62%)

Hot Stocks
Yatra terminates merger agreement with Ebix, files litigation » 16:33
06/05/20
06/05
16:33
06/05/20
16:33
YTRA

Yatra

$1.50 /

+0.24 (+19.05%)

, EBIX

Ebix

$28.32 /

+1.25 (+4.62%)

Yatra (YTRA) announced…

Yatra (YTRA) announced that it has provided notice of termination of its pending merger agreement with Ebix (EBIX) and filed litigation in the Court of Chancery of the State of Delaware over Ebix's breaches of the merger agreement. The complaint seeks to hold Ebix accountable for breaches of its representations, warranties and covenants in the merger agreement and an ancillary extension agreement and seeks substantial damages. Yatra said, "As detailed in the complaint, Ebix's conduct breached material terms of the agreements and frustrated Yatra's ability to close the transaction and obtain the benefit of Yatra's bargain for Yatra's stockholders."

ShowHide Related Items >><<
YTRA Yatra
$1.50 /

+0.24 (+19.05%)

EBIX Ebix
$28.32 /

+1.25 (+4.62%)

YTRA Yatra
$1.50 /

+0.24 (+19.05%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
EBIX Ebix
$28.32 /

+1.25 (+4.62%)

05/12/20 Craig-Hallum
Ebix shares and estimates 'have put in a floor,' says Craig-Hallum
05/12/20 BMO Capital
Ebix price target lowered to $34 from $43 at BMO Capital
04/30/20 Craig-Hallum
Ebix price target lowered to $75 from $80 at Craig-Hallum
03/26/20 Craig-Hallum
Ebix to be top performer as investors realize stock mispriced, says Craig-Hallum
EBIX Ebix
$28.32 /

+1.25 (+4.62%)

EBIX Ebix
$28.32 /

+1.25 (+4.62%)

Over a quarter ago
Hot Stocks
BlueCrest Capital reports 5.1% passive stake in Yatra » 16:25
01/24/20
01/24
16:25
01/24/20
16:25
YTRA

Yatra

$3.50 /

-0.07 (-1.96%)

BlueCrest Capital…

BlueCrest Capital disclosed a 5.1% stake in Yatra, which represents over 2.04M shares. The filing does not allow for activism.

ShowHide Related Items >><<
YTRA Yatra
$3.50 /

-0.07 (-1.96%)

11/13/19 BMO Capital
Ebix price target lowered to $46 from $50 at BMO Capital
02/04/19 Oppenheimer
Oppenheimer downgrades Yatra to Perform on lack of catalysts
02/04/19 Oppenheimer
Yatra downgraded to Perform from Outperform at Oppenheimer
Recommendations
Ebix price target lowered to $46 from $50 at BMO Capital » 07:18
11/13/19
11/13
07:18
11/13/19
07:18
EBIX

Ebix

$36.48 /

-4.48 (-10.94%)

, YTRA

Yatra

$3.83 /

-0.37 (-8.81%)

BMO Capital analyst James…

BMO Capital analyst James Fotheringham lowered his price target on Ebix (EBIX) to $46 and kept his Market Perform rating after its "broad-based" Q3 miss, also reducing his forward estimates by up to 5% with slower expected revenue growth and higher operating expenses. The analyst says he would turn more constructive on the stock after the potential events around the closing of its Yatra Online (YTRA) deal and EbixCash IPO in Q2 of next year.

ShowHide Related Items >><<
EBIX Ebix
$36.48 /

-4.48 (-10.94%)

05/10/19 Maxim
Ebix price target raised to $124 from $113 at Maxim
03/05/19 BMO Capital
Ebix price target lowered to $62 from $75 at BMO Capital
01/11/19 Craig-Hallum
Ebix shares should be owned into 2019, says Craig-Hallum
YTRA Yatra
$3.83 /

-0.37 (-8.81%)

02/04/19 Oppenheimer
Oppenheimer downgrades Yatra to Perform on lack of catalysts
02/04/19 Oppenheimer
Yatra downgraded to Perform from Outperform at Oppenheimer

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.